|Bid||21.69 x 800|
|Ask||21.66 x 800|
|Day's Range||21.32 - 21.79|
|52 Week Range||18.75 - 41.27|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Anyone researching CareDx, Inc (NASDAQ:CDNA) might want to consider the historical volatility of the share price...
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second quarter. One of these stocks was CareDx, Inc. (NASDAQ:CDNA). CareDx, Inc. (NASDAQ:CDNA) was in 22 hedge […]
CareDx, Inc (NASDAQ:CDNA) shareholders might be concerned after seeing the share price drop 27% in the last month. But...
CareDx (CDNA) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Oct. 31) Allergan plc (NYSE: AGN ) Amgen, Inc. (NASDAQ: AMGN ...
Is CareDx, Inc. (NASDAQ:CDNA) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise to work. […]
CEO of Caredx Inc (30-Year Financial, Insider Trades) Peter Maag (insider trades) sold 50,000 shares of CDNA on 08/06/2019 at an average price of $28.84 a share. Continue reading...
CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In his "Homework" segment of "Mad Money" Wednesday, Jim Cramer followed up on a few stocks that had stumped him during earlier shows. Jim said he likes the story at CareDx Inc. , a molecular diagnostics company, but that investors need to wait for a pullback in this speculative stock after it rallied 212% in the last 12 months. In this daily bar chart of CDNA, below, we can see a strong uptrend with a number of consolidations and pullbacks giving traders and investors several buying opportunities along the way.
President Trump signed an executive order Wednesday that will encourage an increase in kidney transplants. This transplant diagnostic company stands to grow significantly, while dialysis companies will take a hit.
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we've gathered as a result gives us access to a wealth of collective knowledge based on these firms' portfolio holdings as of March 31. In this […]